Abstract
BACKGROUND Home-based laboratory services (HBLS), in which specimens are collected at home for analysis in a hospital laboratory, are expanding in aging societies. Who uses them, what patients can pay, and what professionals require before trusting a tool that allocates them remain poorly described in middle-income Asian health systems. OBJECTIVE We aimed to (1) identify determinants of HBLS use within Andersen's Behavioral Model, (2) quantify users' preferences, travel burden, and acceptable fee, (3) elicit stakeholder requirements for a clinical decision support system (CDSS) allocating HBLS, and (4) integrate the strands into design requirements. METHODS This convergent mixed methods study at a tertiary referral center in Bangkok, Thailand, analyzed 95,818 laboratory records of 12,458 adults with chronic disease (67% aged ≥60 years; 2021-2022) and modeled ever-use of HBLS (3946 users vs 8512 never-users) by multivariable logistic regression on predisposing, enabling, and need factors. A survey of 400 users rated 20 decision factors and reported testing frequency, travel cost, and acceptable fee. Twenty semistructured interviews (8 physicians, 7 medical technologists, 3 hospital administrators, and 2 private-sector executives) underwent reflexive thematic analysis. Strands were integrated through a joint display coded for convergence, complementarity, expansion, and divergence. RESULTS Need factors had the largest adjusted odds ratios (aORs): 9.42 (95% CI 7.32-12.11) for being bedbound, 5.97 (95% CI 5.18-6.87) for being homebound, 4.67 (95% CI 3.93-5.56) for ≥3 comorbidities, and 4.18 (95% CI 3.44-5.09) for age ≥80 years. Taxi reliance (aOR 5.83, 95% CI 5.02-6.76), not working (aOR 5.21, 95% CI 4.57-5.95), and a caregiver at home (aOR 2.47, 95% CI 2.17-2.83) increased use; Social Security Scheme coverage reduced it (aOR 0.13, 95% CI 0.11-0.16) vs the Universal Coverage Scheme; estimates were similar in patients aged ≥60 years. Survey respondents were mostly older (89.0% aged >60 years) and low-income (79.0% below 10,000 Thai baht [THB] monthly); the factors most often rated most important were age (69.5%), inability to care for oneself (62.0%), and difficulty traveling (60.3%). Over half (58.0%) spent >500 THB per visit on travel, 69.7% (of 393) named 300-500 THB as an acceptable fee, and 97.0% intended to reuse the service. Six themes emerged: all groups agreed that stable chronic disease monitoring is the target, but physicians required advisory, overridable recommendations while technologists required nonnegotiable specimen rules. Integration yielded 4 meta-inferences and 12 design requirements, including 2-tier governance: a hard specimen-safety gate and an advisory patient-selection layer. CONCLUSIONS HBLS use is driven by functional dependency and multimorbidity rather than demographic convenience, concentrates among low-income older adults whose travel costs exceed the fee they find acceptable, and is trusted by professionals when specimen integrity is nonnegotiable and clinical judgment is preserved. These findings supply eligibility, financing, and governance requirements for CDSSs allocating home-based diagnostics to older adults.

This publication has 82 references indexed in Scilit: